| 1 |
Genotyping HLA alleles to predict the development of Severe cutaneous adverse drug reactions (SCARs): state-of-the-art |
|
| | Thawinee Jantararoungtong, Therdpong Tempark, Napatrupron Koomdee, Sadeep Medhasi, Chonlaphat Sukasem | | | Expert Opinion on Drug Metabolism & Toxicology. 2021; 17(9): 1049 | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Response: “Distinguishing Stevens-Johnson syndrome/toxic epidermal necrolysis from clinical mimickers during inpatient dermatologic consultation—A retrospective chart review” |
|
| | Corey Georgesen, Sabrina A. Karim, Rebecca Liu, Autumn Moorhead, Louis D. Falo, Joseph C. English | | | Journal of the American Academy of Dermatology. 2020; 82(3): e111 | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Epidemiology and Risk Factors for Severe Delayed Drug Hypersensitivity Reactions |
|
| | Eva S.R. Gomes, Maria L. Marques, Frederico S. Regateiro | | | Current Pharmaceutical Design. 2019; 25(36): 3799 | | | [Pubmed] [Google Scholar] [DOI] | |
|
